Posts Tagged ‘Switzerland’
Moonlight AI AG Raises $3.3M Seed Round
Moonlight AI AG, a Swiss startup building image analysis software for clinical-grade diagnostics, has closed a $3.3 million USD Seed round. The investment was co-led by Lotus One Investment (Singapore), VP Venture Partners (Switzerland), and MEDIN Fund (Tunisia), with participation from N&V Capital (Liechtenstein) and existing investor QAI Ventures (Switzerland). Turning routine slide images into…
Read MoreSwiss Biotech on the Rise: Strong Momentum in 2025
Switzerland’s biotech sector continues to demonstrate remarkable resilience and growth, even in a complex global environment. According to the latest Swiss Biotech Report 2026, the industry reached new heights in 2025—both in terms of revenue and investment—further strengthening the country’s position as a global life sciences powerhouse. Record performance in a challenging context The numbers…
Read MoreFour Vaud-based Projects Awarded FIT Impact Grants
Four innovative projects from the canton of Vaud have each been awarded a CHF 10,000 grant from the FIT Fondation pour l’Innovation Technologique through its FIT Impact program. Emerging from University of Lausanne (UNIL) and the H4 ecosystem, the selected initiatives—FineTouch Academy, Phonemia, SODA, and TYTOdb—address key challenges in healthcare, education, and environmental monitoring. FineTouch…
Read MoreVenture Leaders Biotech 2026: 10 innovative biotech startups selected for the Boston roadshow
Ten startups, 4 of them from the Swiss Health Valley, have been selected for the 2026 Venture Leaders Biotech programme, which will take them to Boston from May 31st to June 5th as part of the Swiss National Startup Team. During their roadshow, the entrepreneurs will connect with international investors and industry leaders, acquiring expertise…
Read MoreXsensio SA Raises $7 Million in Oversubscribed Series A Funding
Xsensio SA, a Vaud-based high-tech company pioneering continuous biochemical monitoring in near real time, announced the closing of a Series A funding round with an oversubscription of $7 million. The round was led by San Francisco-based venture capital firm WI Harper, with participation from Privilège Ventures, the European Innovation Council and private investors from the…
Read MoreKYLYS AESTHETICS SA Completes its First Clinical Trial
KYLYS AESTHETICS SA, a University of Geneva spinoff and Swiss clinical-stage biotech company developing next-generation regenerative aesthetic medical devices, announces the successful completion of patient injections in its first clinical trial. A total of 55 patients have now been treated as part of this study evaluating the company’s proprietary hyaluronic acid-based injectable technology. This milestone…
Read MoreNose Switzerland Gets a FIF Seed Impact Grant
Nose Switzerland is addressing malnutrition in cancer patients with taste and smell disorders. The project got a CHF 20,000 FIF Seed Impact Grant. Developed in close collaboration with researchers from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE), Nose Switzerland addresses a pressing but often overlooked consequence of cancer treatment: chemosensory dysfunction. Patients who undergo…
Read MoreTimeline Partners with Lancôme
Swiss biotech Timeline, born at EPFL Innovation Park, has entered a landmark global partnership with Lancôme, the flagship beauty brand of L’Oréal. The collaboration marks the first worldwide large-scale commercialization of Timeline’s proprietary longevity molecule, Mitopure®, within a global skincare brand. For Timeline, this partnership represents the culmination of nearly two decades of scientific research…
Read MoreDSM-Firmenich Divests its Animal Nutrition and Health business
The Dutch-Swiss group DSM-Firmenich announced that it will sell its animal nutrition and health business to the investment fund CVC Capital Partners based on an enterprise value of €2.2 billion. A move that marks the completion of the group’s strategic transformation towards the nutrition, health, and beauty markets for human use. With this sale, the…
Read MorePfizer Prize: HUG, UNIL and UNIFR Researchers Awarded
Three Swiss Health Valley research projects have been awarded the Prix Pfizer de la recherche biomédicale 2026, showcasing innovation across cancer immunotherapy, digital health, and personalized medicine. Each project received a CHF 20,000 grant. Personalized cancer vaccine – HUGA research team led by Nicolas Mach, together with Rémi Vernet and Eugenio Fernandez at the HUG…
Read More